Enantioselective syntheses of dopaminergic (R)- and (S)-benzyltetrahydroisoquinolines

被引:44
作者
Cabedo, N
Andreu, I
de Arellano, MCR
Chagraoui, A
Serrano, A
Bermejo, A
Protais, P
Cortes, D [1 ]
机构
[1] Univ Valencia, Dept Farmacol, Lab Farmacognosia, E-46100 Valencia, Spain
[2] Univ Valencia, Dept Quim Organ, E-46100 Valencia, Spain
[3] UFR Med Pharm, Physiol Lab, F-76183 Rouen, France
关键词
D O I
10.1021/jm001128u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Optically pure (1S,R)- and (1R,S)-benzyltetrahydroisoquinolines (BTHIQs), 12a,b as the major diastereomers, were prepared by stereoselective reduction of the isoquinolinium salt possessing (R)- and (S)-phenylglycinol as the chiral auxiliary, respectively. The absolute configurations of(1S,R)-13a hydrochloride (O-debenzoylated derivative from 12a) and (1R,S)-12b, diastereomers were unambiguously determined by single-crystal X-ray analysis. Reductive removal of the chiral auxiliary group, subsequent N-propylation, and cleavage of the methylenedioxy group furnished the optically active catecholamines (1S)-16a and (LR)-16b in good overall yield. We have separately prepared for the first time pairs of dopaminergic 1-BTHIQs enantiomers through a classical methodology in asymmetric synthesis. The (1S)-enantiomers (14a-16a) bind to D-1 and D-2 dopamine receptors with affinities 5-15 times higher than those of the corresponding (1R)-enantiomers (14b-16b). Moreover, (1S)-14a inhibits [H-3]dopamine uptake with high affinity. It appears that synthesis and testing of(S)-enantiomers of BTHIQ are very important for the search for new active drugs at dopamine receptors.
引用
收藏
页码:1794 / 1801
页数:8
相关论文
共 23 条
[1]   Preparation of dopaminergic N-alkyl-benzyltetrahydroisoquinolines using a 'one-pot' procedure in acid medium [J].
Andreu, I ;
Cortes, D ;
Protais, P ;
Cassels, BK ;
Chagraoui, A ;
Cabedo, N .
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (05) :889-895
[2]   Synthesis and dopamine receptor selectivity of the benzyltetrahydroisoquinoline, (R)-(+)-nor-roefractine [J].
Cabedo, N ;
Protais, P ;
Cassels, BK ;
Cortes, D .
JOURNAL OF NATURAL PRODUCTS, 1998, 61 (06) :709-712
[3]  
CLARIFSON PS, 1988, J MED CHEM, V31, P1941
[4]   Chiral auxiliary mediated Pictet-Spengler reactions - Asymmetric syntheses of (-)-laudanosine, (+)-glaucine and (-)-xylopinine. [J].
Comins, DL ;
Thakker, PM ;
Baevsky, MF ;
Badawi, MM .
TETRAHEDRON, 1997, 53 (48) :16327-16340
[5]   trans-2,6-, 3,6-and 4,6-diaza-5,6,6a,7,8,12b-hexahydrobenzo[C]phenanthrene-10,11-diols as dopamine agonists [J].
Gu, YG ;
Bayburt, EK ;
Michaelides, MR ;
Lin, CW ;
Shiosaki, K .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (10) :1341-1346
[6]   D-4 dopamine receptor-selective compounds from the Chinese plant Phoebe chekiangensis [J].
Hegde, VR ;
Dai, P ;
Ladislaw, C ;
Patel, MG ;
Puar, MS ;
Pachter, JA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (09) :1207-1212
[7]  
Jullian V, 2000, EUR J ORG CHEM, V2000, P1319, DOI 10.1002/1099-0690(200004)2000:7<1319::AID-EJOC1319>3.0.CO
[8]  
2-J
[9]   Inhibition of dopamine receptors by endogenous amines: Binding to striatal receptors and pharmacological effects on locomotor activity [J].
Kawai, H ;
Kotake, Y ;
Ohta, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (15) :1669-1671
[10]   RECENT PROGRESS USING CHIRAL FORMAMIDINES IN ASYMMETRIC SYNTHESES [J].
MEYERS, AI .
TETRAHEDRON, 1992, 48 (13) :2589-2612